Integrating Model‐Informed Drug Development With AI: A Synergistic Approach to Accelerating Pharmaceutical Innovation
ABSTRACT The pharmaceutical industry constantly strives to improve drug development processes to reduce costs, increase efficiencies, and enhance therapeutic outcomes for patients. Model‐Informed Drug Development (MIDD) uses mathematical models to simulate intricate processes involved in drug absorp...
Saved in:
Main Authors: | Karthik Raman, Rukmini Kumar, Cynthia J. Musante, Subha Madhavan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Science |
Subjects: | |
Online Access: | https://doi.org/10.1111/cts.70124 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: ChatGPT and other generative AI tools
by: Stefan Küchemann, et al.
Published: (2025-02-01) -
Artificial intelligence driven innovations in biochemistry: A review of emerging research frontiers
by: Mohammed Abdul Lateef Junaid
Published: (2025-01-01) -
Challenges and Prospects of Deploying AI and Machine Learning for Clinical Diagnosis in African Healthcare
by: Edmund Terem Ugar
Published: (2025-01-01) -
Chinese Chat Room: AI Hallucinations, Epistemology and Cognition
by: Šekrst Kristina
Published: (2024-12-01) -
On the role of knowledge graphs in AI-based scientific discovery
by: Mathieu d’Aquin
Published: (2025-01-01)